LXRX
LXRX
US5288723027
Lexicon Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
747.53M EUR
1.07B EUR
661.09M EUR
417.99M EUR
Enterprise Value
651.75M EUR
1.09B EUR
680.71M EUR
446.48M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-8.81x
--
--
--
Price to Sales
18.03x
25.75x
9.49x
8.61x
Price to Book
4.29x
6.12x
3.26x
3.89x
EV/Revenue
15.72x
26.19x
9.77x
9.2x
EV/EBITDA
-12.06x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-5.99%
-6.09%
-5.87%
-5.76%
ende